tiprankstipranks
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
US Market

CASI Pharmaceuticals (CASI) Balance Sheet

430 Followers

CASI Pharmaceuticals Balance Sheet

CASI Pharmaceuticals's total assets for Q4 2023 were $75.27M, a decrease of -21.79% from the previous quarter. CASI total liabilities were $51.10M for the fiscal quarter, a 74.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 75.27M$ 96.23M$ 138.30M$ 127.73M$ 102.63M
Total Liabilities
$ 51.10M$ 29.30M$ 30.34M$ 46.19M$ 29.64M
Total Equity Gross Minority
$ 24.16M$ 66.89M$ 107.96M$ 81.54M$ 73.00M
Total Capitalization
$ 43.06M$ 44.53M$ 84.50M$ 81.54M$ 73.00M
Preferred Stock Equity
-----
Capital Lease Obligations
---$ 1.90M$ 2.20M
Currency in USD

CASI Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis